# A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants

> **NCT06554821** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 28 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT06554821
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-05
- **Primary completion:** 2024-10-08
- **Final completion:** 2024-10-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06554821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06554821, "A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06554821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*